Recalled General Mills flour linked to an ongoing E. coli outbreak has spurred yet another secondary product recall — this time it’s Marie Callender’s cheese biscuit mix. The International
The confirmed case count in the Hepatitis A outbreak on Oahu now stands at 52, according to the Hawaii State Department of Health, up from 31 confirmed cases a week
UPDATED CONTENT 8:30 p.m. EDT — The Canadian Food Inspection Agency has posted a recall notice for Golden Dipt brand jalapeño breader mix distributed in Alberta and possibly nationwide.
A restaurant whose customers have contracted Salmonella infections has repeatedly failed health inspections but has not been closed down by authorities.
The Fadó Irish Pub & Restaurant in Seattle had
UPDATED CONTENT July 13: General Mills Inc. updated its recall notice, removing the regular version of its “Betty Crocker Super Moist Rainbow Bit Cake Mix” distributed in the United States.
The General Mills Inc. recall of 30 million pounds of flour linked to an ongoing E. coli outbreak continues to cause other companies to recall products, with Continental Mills Inc.
Test results are pending in an investigation into a possible Salmonella outbreak among customers of Fadó Irish Pub & Restaurant in Seattle. At least two customers who recently ate at
Media outlets and the Twittersphere are indulging in a feeding frenzy about illnesses possibly linked to Chipotle Mexican Grill locations in New York City, but health officials say no confirmed
Five days after General Mills Inc. tripled the size of its flour recall — now at 30 million pounds — officials in China warned people there to stop using certain bags of
UPDATED CONTENT July 7 — This story has been updated to include reports that the number of E. coli victims in the outbreak has doubled to 50, up from 25. A
After three hours of testimony Tuesday, a federal judge ruled Amos Miller and Miller’s Organic Farm, located at 648 Millcreek School Road in Bird-in-Hand, PA, must submit to inspection
Editor’s note: This blog by FDA’s Stephen Ostroff and Kathleen Gensheimer was originally posted by the agency as part of its “FDA Voice” series on June 28, 2016.